QHRD106 ameliorates ischemic stroke injury as a long-acting tissue kallikrein preparation

Ischemic stroke is the second leading cause of death worldwide, and there are limited effective treatment strategies. QHRD106, a polyethyleneglycol (PEG)-modified long-acting tissue kallikrein preparation, has not been reported previously. In this study, we aimed to investigate the therapeutic effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Si-Yi, Jia, Jun-Qiu, Sun, Min, Bao, Xin-Yu, Xia, Sheng-Nan, Shu, Shu, Liu, Pin-yi, Ji, Sen-lin, Ye, Lei, Cao, Xiang, Xu, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366503/
https://www.ncbi.nlm.nih.gov/pubmed/37496671
http://dx.doi.org/10.1016/j.isci.2023.107268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366503/
https://www.ncbi.nlm.nih.gov/pubmed/37496671
http://dx.doi.org/10.1016/j.isci.2023.107268

Ejemplares similares